LINC01614 and bladder transitional cell carcinoma: High levels of LINC01614 also predict poor DSS for 16 cancer types (Figure 4D), poor DFI for 10 cancers, and poor PFI for 18 cancers, whereas for DFI of BLCA and UCEC patients (Figure 4E) or for PFI of DLBC patients, LINC01614 played a protective role (Figure 4C).